Kiran Nistala Email

Chief Medical Officer . Zura Bio Limited

Current Roles

Employees:
38
Revenue:
$2.1M
About
Zura Bio Limited is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab. ZB-168 is an anti IL7R α inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing Phase 1b data in Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage. Zura Bio is headquartered in San Diego, CA with team members in the UK and USA.
Zura Bio Limited Address
1489 W. Warm Springs Road
San Diego, CA
Zura Bio Limited Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.